Join the Rivastigmine group to help and get support from people like you.
Rivastigmine News
Novartis Exelon Patch Now FDA Approved to Treat Patients Across all Stages of Alzheimer's Disease
EAST HANOVER, N.J., June 27, 2013 /PRNewswire/ – The US Food and Drug Administration (FDA) has expanded the approved indication for Exelon Patch (rivastigmine transdermal system) to include the...
Higher Dose of Novartis Drug Exelon Patch Approved By FDA for Patients With Mild to Moderate Alzheimer's Disease
EAST HANOVER, N.J., Sept. 4, 2012 /PRNewswire/ – The US Food and Drug Administration has approved a higher dose of Exelon Patch (rivastigmine transdermal system) for the treatment of people with...
Further information
Related condition support groups
Alzheimer's Disease, Parkinson's Disease